Vitreoretinal Surgery Devices Market Size to Hit USD 3.21 Billion by 2035 – SNS Insider
Global Vitreoretinal Surgery Devices Market growth is Driven by Increasing Prevalence of Vision-Threatening Retinal Diseases, Expanding Geriatric Population.
Austin, United States, May 11, 2026 (GLOBE NEWSWIRE) — “According to SNS Insider, the Vitreoretinal Surgery Devices Market was valued at USD 2.12 billion in 2025 and is expected to reach USD 3.21 billion by 2035, growing at a CAGR of 4.27% from 2026–2035.”
The growth of the vitreoretinal surgery devices market is driven by the elevating predominance of retinal scatters, upswing mature grown-up populace, and improvement in progressed ophthalmic careful measures.
Vitreoretinal Surgery Devices Market Size & Forecast
- Market Size (2025): USD 2.12 Billion
- Projected Market Size (2035): USD 3.21 Billion
- CAGR (2026–2035): 4.27%
- Forecast Period: 2026–2035
- Base Year: 2025
Get a Sample Report of Vitreoretinal Surgery Devices Market: https://www.snsinsider.com/sample-request/10160
The United States Vitreoretinal Surgery Devices Market was valued at USD 1.89 billion in 2025 and is expected to reach USD 2.80 billion by 2035, growing at a CAGR of 6.17% from 2026–2035.
With a concentration of top ophthalmic device manufacturers like Alcon, Bausch + Lomb, Carl Zeiss Meditec, and Topcon Corporation, as well as a sophisticated healthcare infrastructure and strong reimbursement frameworks, the U.S. Vitreoretinal Surgery Devices Market is the largest in the world. Hospital systems and ambulatory surgery centers continue to implement sophisticated retinal operations due to favorable Centers for Medicare & Medicaid Services (CMS) reimbursement rules.
Rising Disease Burden and Demographic Shifts Augment Market Expansion Globally
The growing incidence of retinal conditions such diabetic retinopathy, age-related macular degeneration (AMD), and retinal detachment, which are mostly caused by aging populations and an increase in lifestyle diseases like diabetes, is driving the demand for vitreoretinal surgery. Higher rates of surgical intervention are partly a result of increased knowledge and early detection of eye disorders. Furthermore, improvements in vitrectomy instruments, improved vision systems, and less invasive surgical techniques are boosting procedure efficiency and safety, promoting broader usage. Global market growth is being further accelerated by increased access to specialized ophthalmic care and the expansion of healthcare infrastructure, especially in emerging nations.
Major Vitreoretinal Surgery Devices Market Companies Listed in the Report are
- Alcon Inc.
- Johnson & Johnson Vision
- Bausch + Lomb Incorporated
- Carl Zeiss Meditec AG
- Topcon Corporation
- NIDEK Co., Ltd.
- HOYA Corporation
- DORC (Dutch Ophthalmic Research Center)
- IRIDEX Corporation
- Lumenis Ltd.
- BVI Medical
- GEUDER AG
- OCULUS Optikgeräte GmbH
- Optos plc
- Ellex Medical Lasers Ltd.
- Synergetics USA Inc.
- Leica Microsystems GmbH
- MedOne Surgical Inc.
- Katalyst Surgical LLC
- Peregrine Surgical Ltd.
Segmentation Analysis:
By Product Type
Vitrectomy Surgery Devices dominated the Vitreoretinal Surgery Devices Market with 34.81% share in 2025 due to the importance of large number of vitrectomy devices globally. The Illumination Surgery Devices segment is expected to be the fastest-growing segment during 2026-2035 owing to the rising use of advanced visualization technologies such as inclusion of fiber optic and LED based illumination with 3D surgical systems.
By Application
Diabetic Retinopathy dominated the Vitreoretinal Surgery Devices Market with 31.40% share in 2025 due to the rapidly increasing global burden of diabetes. Epiretinal Membrane Removal segment is projected to achieve growth at a faster pace during the forecast period due to the Epiretinal Membrane segment is projected to achieve growth at a faster pace during the forecast period.
By Surgery Type
Vitreoretinal Surgery Devices dominated the Vitreoretinal Surgery Devices Market with 46.35% share in 2025 and is also projected to grow with the fastest CAGR globally driven by widespread adoption of micro-incision techniques.
By End User
Hospitals dominated the Vitreoretinal Surgery Devices Market with 48.60% share in 2025 as complex retinal surgeries require advanced infrastructure, specialized surgical teams, and high-end imaging systems. The Ambulatory Surgical Centers (ASCs) is expected to be the fastest growing segment in the market owing to cost-effectiveness of an ambulatory approach and patients’ preference for same-day procedures.
Do you have any specific queries or need any customization research on Vitreoretinal Surgery Devices Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/10160
Vitreoretinal Surgery Devices Market Key Segments
By Product Type
- Vitrectomy Surgery Devices
- Photocoagulation Surgery Devices
- Illumination Surgery Devices
- Others
By Application
- Diabetic Retinopathy
- Retinal Detachment
- Macular Hole Surgery
- Epiretinal Membrane Removal
- Other Vitreoretinal Disorders
By Surgery Type
- Traditional Surgery
- Minimally Invasive Surgery
- Laser-Assisted Surgery
By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Ophthalmic Clinics
- Research Institutes
Regional Insights:
Due to its sophisticated ophthalmic healthcare infrastructure, higher socioeconomic status, high prevalence of retinal disorders, and greater number of top medical device companies, North America continued to be the largest region and held a 41% share of the global Vitreoretinal Surgery Devices Market revenue at its peak.
During the forecast period (2026–2035), the Asia Pacific region is expected to maintain the highest CAGR of 16.80% due to rapidly developing ophthalmic healthcare infrastructure, rising awareness of different retinal treatment options, rising prevalence of diabetes-related eye diseases, and significant government investment in healthcare modernization.
Recent Developments:
- 2026: Bausch + Lomb receives FDA 510(k) clearance for the Bi-Blade + dual-port vitrectomy cutter (and also the Adaptive Fluidics upgrade for Stellaris Elite, which allows cutting speed of up to 25,000 cuts per minute and improved intraoperative fluidic stability in retinal surgery).
- 2025: Alcon launched limited global commercialization of its new state-of-the-art UNITY Vitreoretinal Cataract System (VCS), featuring next-generation elements such as 30,000 cuts-per-minute vitrectomy technology and Intelligent Fluidics to offer the greatest precision and efficiency across both vitreoretinal and cataract surgical procedures.
Exclusive Sections of the Report (The USPs):
- MINIMALLY INVASIVE SURGICAL ADOPTION METRICS – helps you understand the adoption trends of minimally invasive vitreoretinal surgical systems (MIVS), outpatient retinal procedures, and the growing role of ambulatory surgical centers across global healthcare markets.
- SURGICAL PERFORMANCE & PRECISION ANALYSIS – helps you evaluate improvements in surgical precision, retinal detachment success rates, diabetic retinopathy treatment outcomes, device reliability, and imaging accuracy enabled by advanced vitreoretinal technologies.
- ADVANCED VISUALIZATION & DIGITAL SURGERY INSIGHTS – helps you uncover opportunities in intraoperative OCT, 3D heads-up displays, AI-assisted surgical guidance, robotic-assisted retinal surgery, and real-time digital imaging platforms.
- TECHNOLOGY INNOVATION & REGULATORY APPROVAL METRICS – helps you analyze R&D investments, annual regulatory approvals, integration of smart surgical technologies, and advancements in micro-incision instruments, high-speed cutters, and advanced fluidics systems.
- HEALTHCARE INFRASTRUCTURE & PROCEDURE SHIFT ANALYSIS – helps you identify how healthcare expenditure trends, ASC expansion, and regional ophthalmic infrastructure development are influencing vitreoretinal surgery device adoption globally.
- COMPETITIVE LANDSCAPE & MARKET POSITIONING – helps you gauge the competitive strength of leading ophthalmic device manufacturers based on innovation capabilities, product portfolios, regulatory approvals, technological advancements, and global expansion strategies.
Buy an Enterprise-User PDF of Vitreoretinal Surgery Devices Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/10160
Vitreoretinal Surgery Devices Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 2.12 Billion |
| Market Size by 2035 | USD 3.21 Billion |
| CAGR | CAGR of 4.27% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
Ophthalmic Diagnostic Devices Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.
